BriaCell Awarded Research Grant from Wiseman Cancer Research Foundation

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 04, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (a??BriaCella?? or the a??Companya??) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is announcing that it has received a research grant from the Wiseman Cancer Research Foundation, a 501c(3) nonprofit organization based in Beverly Hills, CA. The research grants are awarded to individual scientists or entities that pursue outstanding research in immuno-oncology. Dr. Charles L. Wiseman, BriaCella??s Scientific Founder and Director, currently serves as President of the Wiseman Cancer Research Foundation.
a??We are grateful for the support that we have received from the Wiseman Cancer Research Foundation, and are honored to have received the award,a?? said Dr. Bill Williams, BriaCella??s President and CEO.On a separate note, BriaCella??s Senior Director, R&D, Markus Lacher, Ph.D., has left BriaCell to pursue other career interests.a??Markus has done a great job over the past several years in our R&D division. On behalf of BriaCell team, I want to thank Markus for his leadership and commitment to BriaCell, and wish him all the best in his future endeavors,a?? said Dr. Williams.About BriaCell
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »